IKKβ is a potential anti-angiogenic therapeutic target in KRAS-induced lung cancer (2016)
Source: Abstracts. Conference titles: Precision Medicine Series: Targeting the Vulnerabilities of Cancer. Unidade: IQ
Assunto: NEOPLASIAS PULMONARES
ABNT
BASSÈRES, Daniela Sanchez. IKKβ is a potential anti-angiogenic therapeutic target in KRAS-induced lung cancer. 2016, Anais.. Philadelphia: American Association for Cancer Research, 2016. . Acesso em: 31 out. 2024.APA
Bassères, D. S. (2016). IKKβ is a potential anti-angiogenic therapeutic target in KRAS-induced lung cancer. In Abstracts. Philadelphia: American Association for Cancer Research.NLM
Bassères DS. IKKβ is a potential anti-angiogenic therapeutic target in KRAS-induced lung cancer. Abstracts. 2016 ;[citado 2024 out. 31 ]Vancouver
Bassères DS. IKKβ is a potential anti-angiogenic therapeutic target in KRAS-induced lung cancer. Abstracts. 2016 ;[citado 2024 out. 31 ]